Lilly rides Mounjaro, Zepbound to better
Release time：2024-05-01 06:21:02 Source：International Illustrations news portal
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
- Previous：Walmart shutting down its 51 health care clinics, virtual care service
- Next：New Jersey seeks fourth round of offshore wind farm proposals as foes push back
Related articles
- Swiatek rallies against Haddad Maia to reach Madrid Open semis
- China Issues List of Universities for Top
- Chinese Procurators Help Schools Promote Legal Work, Campus Security
- China's Judicial Authorities Strengthen Protection of Women, Children
- Scotland Yard to pay 'five
- Chinese Procurators Help Schools Promote Legal Work, Campus Security
- China's Ma Long, Wang Manyu through at WTT Champions
- People Around China Celebrate Chinese Lunar New Year
- Immigrant's $1.3B Powerball win spotlights the Iu Mien community
- Migrant Workers' Life in East China's Huzhou
- Rhod Gilbert shares cancer update as he admits he's 'pinching himself' over performing stand
- Beijing Winter Olympic Medals Pass Acceptance Test
- Seminar Discusses Gender Equality in Context of Climate Change, Biodiversity Loss
- Salary Climbing for Returning Graduates
- Using a walker boot for too long may mean you can't ever walk properly without it again
- Children's Health Continues to Improve
- Shanghai Promotes Community Libraries
- China Pledges to Further Support Employment of People Emerging from Poverty
- Family appeals ruling that threw out lawsuit over 2017 BIA shooting death in North Dakota
- Migrant Workers' Life in East China's Huzhou
Random recommendation
- Copyright © 2024 Powered by Lilly rides Mounjaro, Zepbound to better ,International Illustrations news portal sitemap